Mesothelioma Clinical Trials


Study Status Age Phase
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma Recruiting Adult,Senior NA
Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma Recruiting Adult,Senior NA
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity Completed Adult,Senior Phase 2
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy Active, not recruiting Adult,Senior Phase 2
Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma. Recruiting Adult,Senior NA
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma Active, not recruiting Adult,Senior Phase 1
Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos Recruiting Adult,Senior NA
Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma Recruiting Adult,Senior Phase 2
Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma Completed Adult,Senior Phase 2
Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma Recruiting Adult,Senior Phase 2
Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma Completed Adult,Senior Phase 2
SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma Active, not recruiting Adult,Senior Phase 1
An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma Completed Adult,Senior Phase 2
Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma Recruiting Adult,Senior Phase 1
SU5416 in Treating Patients With Malignant Mesothelioma Completed Adult,Senior Phase 2
Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma Completed Adult,Senior Phase 2
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma Active, not recruiting Adult,Senior Phase 1
Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma Active, not recruiting Child,Adult,Senior Phase 2
Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma Active, not recruiting Child,Adult,Senior Phase 1
Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma Completed Adult,Senior Phase 3
Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma Completed Adult,Senior Phase 3
Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma Completed Adult,Senior Phase 2
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura Completed Adult,Senior Phase 3
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma Completed Adult,Senior Phase 2
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma Recruiting Adult,Senior Phase 1
Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery Completed Adult,Senior Phase 3
Response Evaluation in Malignant Pleural Mesothelioma Active, not recruiting Adult,Senior NA
Tomotherapy Treatment for Mesothelioma Active, not recruiting Adult,Senior Phase 2
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma Recruiting Adult,Senior Phase 2
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen Active, not recruiting Adult,Senior Phase 3
Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (0683-014 AM5, EXT1) Completed Adult,Senior Phase 3
Gefitinib in Treating Patients With Malignant Mesothelioma Completed Adult,Senior Phase 2
A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma Withdrawn Adult,Senior NA
Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers Recruiting Adult,Senior NA
Bortezomib in Treating Patients With Malignant Pleural Mesothelioma Completed Adult,Senior Phase 2
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma Completed Adult,Senior Phase 2
Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma Recruiting Child,Adult,Senior Phase 1
Capecitabine in Treating Patients With Malignant Mesothelioma Completed Adult,Senior Phase 2
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma Completed Adult,Senior Phase 2
Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma Active, not recruiting Child,Adult,Senior Phase 2
Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma Recruiting Adult,Senior Phase 2
Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed Completed Adult,Senior Phase 2
Dasatinib in Resectable Malignant Pleural Mesothelioma Active, not recruiting Adult,Senior Phase 1
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma Completed Adult,Senior Phase 2
Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma Completed Adult,Senior Phase 2
Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma Terminated Child,Adult,Senior Phase 2
Dendritic Cell-based Immunotherapy in Mesothelioma Completed Adult,Senior Phase 1
Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma Completed Child,Adult,Senior Phase 2
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery Completed Adult,Senior Phase 2
Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung Completed Adult,Senior Phase 2
S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery Completed Adult,Senior Phase 2
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma Active, not recruiting Adult,Senior NA
Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma Terminated Adult,Senior Phase 2
Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma Active, not recruiting Child,Adult,Senior Phase 3
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107 Completed Adult,Senior NA
Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma Active, not recruiting Adult,Senior Phase 2
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery Active, not recruiting Adult,Senior Phase 2
Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery Active, not recruiting Adult,Senior NA
Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment Completed Adult,Senior Phase 2
Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy Recruiting Adult,Senior Phase 2
CRS-207 Cancer Vaccine in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma Recruiting Adult,Senior Phase 1
Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment Not yet recruiting Adult,Senior NA
Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma Recruiting Adult,Senior Phase 2
Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma Completed Adult,Senior Phase 2
Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery Completed Adult,Senior Phase 2
Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia Recruiting Child,Adult,Senior NA
Pazopanib in Treating Patients With Malignant Pleural Mesothelioma Active, not recruiting Adult,Senior Phase 2
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma Active, not recruiting Adult,Senior Phase 2
Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. Completed Adult,Senior Phase 2
AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma Withdrawn Adult,Senior Phase 2
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery Active, not recruiting Adult,Senior Phase 2
Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung Completed Child,Adult,Senior Phase 2
Axitinib in Malignant Mesothelioma Recruiting Adult,Senior NA
PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma Recruiting Adult,Senior Phase 3
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma Recruiting Adult,Senior NA
Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma Completed Adult,Senior Phase 2
A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma Recruiting Adult,Senior Phase 2
A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma Active, not recruiting Adult,Senior Phase 2
A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma Recruiting Adult,Senior Phase 2
An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma Terminated Adult,Senior Phase 2
PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery Completed Adult,Senior Phase 2
Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) Completed Child,Adult,Senior NA
Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma Completed Adult,Senior Phase 2
Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma Active, not recruiting Adult,Senior Phase 1
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma Recruiting Adult,Senior Phase 2
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma Recruiting Adult,Senior Phase 2
Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite Recruiting Adult,Senior NA
Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma Completed Adult,Senior Phase 2
The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma Recruiting Adult,Senior Phase 2
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma Active, not recruiting Adult,Senior Phase 2
Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma Not yet recruiting Adult,Senior Phase 1
Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma Completed Adult,Senior Phase 2
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma Completed Adult,Senior Phase 1
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma Completed Adult,Senior Phase 1
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas Recruiting Adult,Senior NA
Thromboelastography During Surgery for Malignant Pleural Mesothelioma Not yet recruiting Adult,Senior Phase 0
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma Recruiting Adult,Senior Phase 2
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy Recruiting Adult,Senior Phase 2
Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma Completed Adult,Senior Phase 2
A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma Completed Adult,Senior Phase 3
Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma Recruiting Adult,Senior Phase 2
The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma Recruiting Adult,Senior NA
Ganetespib With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma Recruiting Adult,Senior NA
Randomized Study of Adjuvant WT-1 Analog Peptide Vaccine in Patients With Malignant Pleural Mesothelioma (MPM) After Completion of Combined Modality Therapy Recruiting Adult,Senior Phase 2
Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) Completed Adult,Senior NA
Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma Completed Adult,Senior Phase 2
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) Recruiting Adult,Senior Phase 2
Sorafenib in Previously Treated Malignant Mesothelioma Active, not recruiting Adult,Senior Phase 2
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma Completed Adult,Senior Phase 2
Nintedanib (BIBF 1120) in Mesothelioma Not yet recruiting Adult,Senior Phase 2
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma Recruiting Adult,Senior Phase 2
An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma Active, not recruiting Adult,Senior Phase 2
Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma Completed Adult,Senior Phase 1
Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma Completed Adult,Senior Phase 2
A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma Withdrawn Adult,Senior NA
Intracavitary Cisplatin-Fibrin Localized Chemotherapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma Recruiting Adult,Senior NA
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma Recruiting Adult,Senior Phase 2
A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma Not yet recruiting Adult,Senior Phase 2
Trimodality Therapy for Malignant Pleural Mesothelioma Recruiting Adult,Senior NA
Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM) Terminated Adult,Senior NA
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma Completed Adult,Senior NA
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura Completed Adult,Senior Phase 1
Phase II Study of Adjuvant WT-1 Analog Peptide Vaccine in MPM Patients After MSK10-134 Recruiting Adult,Senior Phase 2
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed Active, not recruiting Adult,Senior Phase 3
A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy Recruiting Adult,Senior Phase 2
Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer Terminated Adult,Senior NA
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma. Recruiting Adult,Senior Phase 2
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer Completed Adult,Senior Phase 1
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide Active, not recruiting Adult,Senior Phase 1
Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy Recruiting Child,Adult,Senior NA
Combination Gene Transfer and Chemotherapy Recruiting Adult,Senior Phase 0
Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma Recruiting Adult,Senior Phase 2
Intrapleural Gene Transfer for Pleural Mesothelioma Recruiting Adult,Senior Phase 1
Mesothelioma Avastin Plus Pemetrexed-cisplatin Study Recruiting Adult,Senior NA
Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer Recruiting Adult,Senior NA
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer Active, not recruiting Adult,Senior Phase 2
Molecular Predictors of Pemetrexed and Carboplatin Response in Tumor Samples of a Series of Malignant Pleural Mesothelioma (MPM) Patients and Genotyping for the TSER Polymorphism Active, not recruiting Adult,Senior NA
Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients Recruiting Child,Adult,Senior NA
Tumor Cell Vaccines With ISCOMATRIX(Trademark) Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas Recruiting Adult,Senior Phase 1
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen Completed Adult,Senior Phase 2
Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma Completed Adult,Senior NA
ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma. Approved for marketing Adult,Senior Phase 2
Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT) Active, not recruiting Adult,Senior Phase 1
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy Completed Adult,Senior Phase 2
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions Active, not recruiting Adult,Senior Phase 1
Alanosine in Treating Patients With Cancer Completed Child,Adult,Senior Phase 2
Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate Active, not recruiting Adult,Senior Phase 2
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies Completed Adult,Senior Phase 1
Short Neoadjuvant Hemithoracic IMRT for MPM Recruiting Adult,Senior NA
Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate Recruiting Adult,Senior Phase 2
Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment Terminated Adult,Senior Phase 1
A Study of LY3023414 in Participants With Advanced Cancer Recruiting Adult,Senior Phase 1
Clinical and Histopathologic Characteristics of BAP1 Mutations Recruiting Adult,Senior NA
Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma Completed Adult,Senior Phase 2
A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors Not yet recruiting Adult,Senior Phase 1
N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy Recruiting Adult,Senior NA
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer Active, not recruiting Adult,Senior NA
Autologous Redirected RNA Meso-CIR T Cells Active, not recruiting Adult,Senior Phase 1
Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma Recruiting Adult,Senior Phase 1
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors Completed Adult,Senior Phase 1
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors Completed Child,Adult Phase 2
Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs Completed Adult,Senior Phase 1
Immunotoxin Therapy in Treating Patients With Advanced Cancer Completed Adult,Senior Phase 1
CryoSpray Ablation(tm)Thoracic Patient Registry Withdrawn Adult,Senior NA
Amatuximab for High Mesothelin Cancers Recruiting Adult,Senior Phase 0
CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD) Terminated Adult,Senior Phase 4
Treating Cancer With Anti-mesothelin Modified Lymphocytes Recruiting Adult,Senior NA
Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum Terminated Adult,Senior Phase 1
EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer Terminated Adult,Senior NA
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease Withdrawn Child,Adult,Senior Phase 1
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer Completed Adult,Senior Phase 2
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer Completed Child,Adult,Senior Phase 2
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining Recruiting Adult,Senior NA
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers Completed Adult,Senior NA
Mithramycin for Lung, Esophagus, and Other Chest Cancers Recruiting Adult,Senior Phase 2
Gene Therapy for Pleural Malignancies Active, not recruiting Adult,Senior Phase 1
Dendritic Cell Vaccination for Patients With Solid Tumors Enrolling by invitation Adult,Senior NA
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Active, not recruiting Child,Adult,Senior NA
Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body Withdrawn Adult,Senior NA
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction Completed Adult,Senior Phase 1
Validation of the MiCK Assay Recruiting Adult,Senior NA
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed Recruiting Child,Adult,Senior NA
Early Palliative Care With Standard Oncology Care Versus Standard Oncology Care Alone in Advanced Lung and Non-colorectal Gastrointestinal Malignancies Recruiting Adult,Senior Phase 3
Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis Recruiting Adult,Senior Phase 2
Molecular Analysis of Thoracic Malignancies Recruiting Adult,Senior NA
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors Completed Adult,Senior Phase 1
B-Receptor Signaling in Cardiomyopathy Completed Child,Adult NA
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. Completed Adult,Senior Phase 1
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer Suspended Adult,Senior NA
A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors Completed Adult,Senior Phase 1
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial Completed Adult,Senior NA
Interleukin-12 in Treating Patients With Cancer in the Abdomen Completed Adult,Senior Phase 1
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed Adult,Senior Phase 3
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors Completed Adult,Senior Phase 1
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma Completed Adult,Senior Phase 1
Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) Completed Adult,Senior Phase 2
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer Completed Adult,Senior Phase 1
E-MOSAIC Electronic Tool to Monitor Symptoms Completed Adult,Senior Phase 3
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed Adult,Senior Phase 1
Rapamycin With Grapefruit Juice for Advanced Malignancies Active, not recruiting Adult,Senior Phase 1
Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy Completed Adult,Senior NA
Phase I Study of OSI-930 and Erlotinib in Cancer Tumors Completed Adult,Senior Phase 1
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study Terminated Adult,Senior NA
A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies Suspended Adult,Senior Phase 1
A Study in Non Small Cell Lung Cancer Active, not recruiting Adult,Senior NA
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Completed Child,Adult,Senior Phase 2
Collecting Tumor Samples From Patients With Gynecological Tumors Recruiting Child,Adult,Senior NA
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation Active, not recruiting Adult,Senior Phase 3
Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer Active, not recruiting Adult,Senior Phase 2
A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies Not yet recruiting Adult,Senior Phase 1
Ixabepilone and Pemetrexed/Solid Tumors Withdrawn Adult,Senior Phase 1
Study of Pemetrexed for Second-Line Pancreas Cancer Terminated Adult,Senior Phase 2
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days Terminated Adult,Senior Phase 1
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses Terminated Adult,Senior Phase 1
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer Completed Child,Adult Phase 1
Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer Active, not recruiting Adult,Senior Phase 2
Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2 Completed Adult,Senior Phase 3
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome Terminated Adult,Senior NA

Mesothelioma Lawsuit Evaluation

4584

By submitting this form I agree to the Terms of Use

Find a Doctor

Finding a mesothelioma doctor who is familiar with the disease and its treatment will help to ensure that you receive the best medical care possible. Contact a local specialist today.

Find a Doctor

Clinical Trials

Though there is currently no cure for mesothelioma, various clinical trials are underway to test new drugs and treatments in the fight against this disease. Search active clinical trials.

Find a Clinical Trial

Exposure Sites

Asbestos, the only known cause of mesothelioma cancer, was used for decades in jobsites throughout the country. Review a list of known asbestos exposure locations in your area.

Search Exposure Sites